Pugsley M P, Dworzack D L, Sanders C C, Sanders W E
Antimicrob Agents Chemother. 1984 Apr;25(4):494-6. doi: 10.1128/AAC.25.4.494.
Fifty-eight chronic carriers of Neisseria meningitidis were given 250 mg of Sch 29,482 or placebo orally every 6 h for 4 days. Although 22 of 29 subjects taking Sch 29,482 became culture negative while taking the drug, only five were culture negative 2 weeks posttherapy. There were no significant adverse reactions.
58名脑膜炎奈瑟菌慢性携带者每6小时口服250毫克Sch 29,482或安慰剂,共服用4天。虽然服用Sch 29,482的29名受试者中有22人在服药期间培养结果转为阴性,但治疗后2周只有5人培养结果为阴性。未出现明显不良反应。